Relief Therapeutics Holding AG (RLF) — Capital Reinvestment Ratio
Relief Therapeutics Holding AG (RLF) has a Capital Reinvestment Ratio of 0.04x as of December 2024, meaning it reinvests 0% of its operating cash flow (CHF359.00K) in capital expenditures (CHF14.00K). See Relief Therapeutics Holding AG balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Relief Therapeutics Holding AG Capital Reinvestment Ratio (2006–2006)
This chart tracks Relief Therapeutics Holding AG's Capital Reinvestment Ratio across 1 annual periods. Check RLF total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Relief Therapeutics Holding AG (2006–2006)
Year-by-year Capital Reinvestment Ratio for Relief Therapeutics Holding AG from 2006 to 2006. For live market cap and broader valuation context, see RLF market cap.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2006 | 0.21x | CHF2.28 Million | CHF474.60K | — |